// App-Quantinova.ai

: FREQUENCY AND PROGNOSTIC IMPACT OF ZEB2 H1038/Q1072 MUTATIONS IN CHILDHOOD B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Marketa Zaliova

Principal Investigators

  • Eliska Potuckova

  • Julius Lukes Jr

  • Lucie Winkowska

  • Julia Starkova

  • Iveta Janotova

  • Lucie Sramkova

  • Jan Stary

  • Jan Zuna

  • Martin Stanulla

  • Martin Zimmermann

  • Jean-Pierre Bourquin

  • Cornelia Eckert

  • Gunnar Cario

  • Jan Trka

Medical Centers

  • Department of Paediatric Haematology and Oncology, CLIP Laboratory Centre, 2nd School of Medicine, Charles University, Prague, Czech Republic

  • Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

  • Division of Pediatric Neurology, University Childrens Hospital of Zurich, Zurich,Switzerland

  • Department of Pediatric Oncology/Hematology, Charite Medical University Berlin, Berlin, Germany.

  • Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany

Locations

  • Czech Republic

  • Germany

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Zinc finger E-box binding homeobox 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved